Valiant Laboratories Limited Valiant Laboratories Limited

Valiant Laboratories Limited

VALIANTLAB

Rank in Stocks #21839
Valiant Laboratories Limited, an India-based company, specializes in the... Valiant Laboratories Limited, an India-based company, specializes in the production of active pharmaceutical ingredients (APIs) and bulk drugs, serving both domestic and international markets. Its primary product is paracetamol, manufactured in various grades that meet Indian, British, European, and United States pharmacopoeia standards. This crucial compound is utilized in treatments for common ailments such as headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. Beyond pharmaceuticals, the company also supplies specialty chemicals. Originally established in 1980 and headquartered in Mumbai, India, the firm rebranded as Valiant Laboratories Limited in August 2021, having previously operated under the name Bharat Chemicals. It functions as a subsidiary of Dhanvallabh Ventures LLP.
Share Price
$1.12
Last synced: 2026-11-13
Market Cap
$60.62M
Change (1 day)
-2.36%
Change (1 year)
23.67%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Valiant Laboratories Limited (VALIANTLAB)

Category

Healthcare
EPS for Valiant Laboratories Limited (VALIANTLAB)
EPS as of September 2026 TTM: $0.03
According to Valiant Laboratories Limited's latest financial reports, its current EPS (TTM) is $0.03. At the end of 2025 the company had an EPS of $-0.01, a decrease compared to its 2024 EPS of 0.00.
EPS history for Valiant Laboratories Limited from 2021 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $0.03 -417.00%
2025 $-0.01 -700.00%
2024 0.00 -98.77%
2023 $0.08 -2.64%
2022 $0.08 -13.31%
2021 $0.10 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$6.03 18,921.77%
DE
$6.01 18,852.05%
DE
$1.53 4,735.65%
JP
$3.66 11,445.74%
CH
$0.45 1,319.56%
IL

Questions about Valiant Laboratories Limited's earnings per share (EPS)

What is Valiant Laboratories Limited's earnings per share (EPS)?

Valiant Laboratories Limited's earnings per share (EPS) over the last twelve months is $0.03, as of Sep 2026.

What was Valiant Laboratories Limited's earnings per share (EPS) in 2025?

In 2025, Valiant Laboratories Limited's earnings per share (EPS) was $-0.01, compared with 0.00 in 2024.

How has Valiant Laboratories Limited's earnings per share (EPS) changed since 2021?

From 2021 to 2025, Valiant Laboratories Limited's earnings per share (EPS) was highest in 2021 ($0.10) and lowest in 2025 ($-0.01).

How does Valiant Laboratories Limited's earnings per share (EPS) compare with similar companies?

Valiant Laboratories Limited's earnings per share (EPS) ($0.03) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.